Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy

• Published in: Molecular vision Vol. 24; pp. 394 - 406
• Main Authors: Abu El-Asrar, Ahmed M, Mohammad, Ghulam, Allegaert, Eef, Ahmad, Ajmal, Siddiquei, Mohammad Mairaj, Alam, Kaiser, Gikandi, Priscilla W, De Hertogh, Gert, Opdenakker, Ghislain
• Format: Journal Article
• Language: English
• Published: United States Molecular Vision 18.05.2018
• Subjects: Angiogenesis; Blood vessels; Diabetes; Diabetes mellitus; Diabetic retinopathy; Endothelial cells; Enzyme-linked immunosorbent assay; Gelatinase B; Immunohistochemistry; Leukocytes; Matrix metalloproteinase; Metalloproteinase; Retinopathy; Reverse transcription; Rodents; Statistical analysis; Stromal cells; Vascular endothelial growth factor; Vascularization; Western blotting
• ISSN: 1090-0535; 1090-0535

Matrix metalloproteinase-14 (MMP-14) is a transmembrane MMP that plays a critical role in promoting angiogenesis. We investigated the expression levels of MMP-14 and correlated the levels with clinical disease activity and with the levels of the angiogenic factors vascular endothelial growth factor (VEGF) and MMP-9 in proliferative diabetic retinopathy (PDR). To reinforce the findings at the functional level, we examined the expression of MMP-14 in the retinas of diabetic rats. Vitreous samples from 34 patients with PDR and 18 nondiabetic patients and epiretinal membranes from 13 patients with PDR and the retinas of rats were studied with enzyme-linked immunosorbent assay, immunohistochemistry, western blotting, and real-time reverse transcription PCR (RT-PCR). The MMP-14, VEGF, and MMP-9 levels were statistically significantly higher in the vitreous samples from patients with PDR than in the samples from the nondiabetic controls (p<0.001 for all comparisons). The MMP-14 levels in patients with PDR with active neovascularization were statistically significantly higher than those in patients with inactive PDR (p<0.001). There were statistically significant positive correlations between levels of MMP-14 and levels of VEGF (r = 0.3; p = 0.032) and MMP-9 (r = 0.54; p<0.001). In the epiretinal membranes, MMP-14 was expressed in vascular endothelial cells, leukocytes, and myofibroblasts. Statistically significant positive correlations were detected between the numbers of blood vessels expressing CD31 and the numbers of blood vessels (r = 0.74; p = 0.004) and stromal cells (r = 0.72; p = 0.005) expressing MMP-14. Statistically significant increases of MMP-14 mRNA and protein were detected in rat retinas after induction of diabetes. These results suggest that MMP-14 is involved in PDR angiogenesis.